Detalles de la búsqueda
1.
Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase.
Hepatology
; 78(5): 1558-1568, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37184202
2.
Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy.
Hepatol Res
; 2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38323994
3.
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.
J Gastroenterol Hepatol
; 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38480009
4.
Risk factors for liver-related and non-liver-related mortality following a sustained virological response after direct-acting antiviral treatment for hepatitis C virus infection in a real-world cohort.
J Viral Hepat
; 30(5): 374-385, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36583600
5.
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.
Clin Gastroenterol Hepatol
; 20(4): 874-885.e4, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34089852
6.
Direct-acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment.
J Viral Hepat
; 29(1): 52-59, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34695288
7.
On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
Liver Int
; 42(1): 59-68, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34687130
8.
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
J Infect Dis
; 224(11): 1890-1899, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33999179
9.
Outcome of nucleos(t)ide analog intervention in patients with preventive or on-demand therapy for hepatitis B virus reactivation.
J Med Virol
; 93(6): 3679-3687, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32940921
10.
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy.
J Infect Dis
; 221(3): 389-399, 2020 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31550363
11.
Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B.
Am J Gastroenterol
; 115(2): 271-280, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31634265
12.
Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients.
Ann Hepatol
; 19(4): 367-372, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32444247
13.
Switching to tenofovir disoproxil fumarate vs continuing treatment in patients with chronic hepatitis B who maintain long-term virological response to entecavir therapy: A randomized trial.
J Med Virol
; 91(7): 1295-1300, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30815880
14.
Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment.
J Gastroenterol Hepatol
; 34(5): 937-946, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30160782
15.
Sequential therapy involving an early switch from entecavir to pegylated interferon-α in Japanese patients with chronic hepatitis B.
Hepatol Res
; 48(6): 459-468, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29314465
16.
Correlation between polymorphism in the inosine triphosphatase and the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapy.
J Gastroenterol Hepatol
; 32(8): 1495-1502, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28109022
17.
Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination.
Ann Hepatol
; 16(5): 734-741, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28809743
18.
Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed.
Int J Mol Sci
; 18(5)2017 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28467359
19.
Randomized trial of combined triple therapy comprising two types of peginterferon with simeprevir in patients with hepatitis C virus genotype 1b.
Hepatol Res
; 46(13): 1311-1320, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26932745
20.
Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs.
Kaohsiung J Med Sci
; 40(2): 188-197, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37885338